Tyra Biosciences (NASDAQ:TYRA) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.59) by 8.47 percent. This is a 36.17 percent decrease over losses of $(0.47) per share from the same period last year.